A5014555728- Autoimmune Bullous Skin Diseases
- Neonatal Respiratory Health Research
- Infant Development and Preterm Care
- melanin and skin pigmentation
- Dermatological and Skeletal Disorders
- Escherichia coli research studies
- Neonatal and Maternal Infections
- Childhood Cancer Survivors' Quality of Life
- Streptococcal Infections and Treatments
- Infant Nutrition and Health
- Tuberous Sclerosis Complex Research
- Trauma Management and Diagnosis
- Polyomavirus and related diseases
- Medical research and treatments
- Congenital limb and hand anomalies
- Restraint-Related Deaths
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Protein Tyrosine Phosphatases
- Medical and Biological Ozone Research
- Autoimmune Neurological Disorders and Treatments
- Autophagy in Disease and Therapy
- Foreign Body Medical Cases
- RNA modifications and cancer
- Herbal Medicine Research Studies
- Genetic Neurodegenerative Diseases
Centre Hospitalier Public du Cotentin
2017-2021
Université de Bordeaux
2015
Objectives The primary objective of this study is to determine the current level patient medication exposure in Level 3 Neonatal Wards (L3NW). secondary evaluate first month life rate prescription not cited Summary Product Characteristics (SmPC). A database containing all prescriptions collected as part a benchmarking program L3NW. Material and methods research two-year observational cohort (2017–2018) with retrospective analysis medications prescribed 29 French Seventeen L3NW are present...
Background: Aminoglycosides are the most prescribed antibiotics in neonatal intensive care units (NICU). Reducing exposure to NICU is highly desirable, particularly through benchmarking methods. Methods: Description of aminoglycosides prescriptions 23 French using same computerized system over a 4-year period (2017-2020). A program prescription was associated. Results: The population included 53,818 patients. Exposition rates gentamicin and amikacin were 31.7% (n = 17,049) 9.1% 4894),...